Louise Sternicki
Dr Louise Sternicki was awarded a PhD in Biochemistry from the University of Adelaide in 2020 and is currently a Research Fellow at the Institute for Biomedicine and Glycomics, Griffith University.
Dr Sternicki’s research expands native mass spectrometry (nMS) capabilities for characterising challenging biomolecules and their interactions. Her research has included industry collaborations with Bayer, Genentech and Takeda, and she is a current member of the ARC Centre for Fragment-Based Design. She was part of the project team awarded the 2023 Ramaciotti Biomedical Research Award ($1M) to establish the first charge detection mass spectrometry instrument in Australia.
Dr Sternicki’s expertise in nMS has been developed with mentorship by Prof Tara Pukala (University of Adelaide, PhD), Prof Ron Quinn (Griffith University, postdoc) and Prof Sally-Ann Poulsen (her current role at Griffith University), and international research placements with Prof Perdita Barran (Chair of Mass Spectrometry in the Department of Chemistry and Director of the Michael Barber Centre for Collaborative Mass Spectrometry, University of Manchester, UK, 2018) and A/Prof Michael Marty (University of Arizona, USA, 2023).
Abstracts this author is presenting: